| 2022-11-10 | Roivant Sciences Ltd. ROIV | director | 8M 1.0825% | $5.00 | $40M | +73.75% | ||
| 2022-04-25 | Roivant Sciences Ltd. ROIV | 10 percent owner | 8,600 0.0012% | $3.91 | $33,635 | +19.01% | ||
| 2022-04-22 | Roivant Sciences Ltd. ROIV | 10 percent owner | 31,685 0.0045% | $3.83 | $121,319 | +22.38% | ||
| 2021-06-03 | Sale | Protalix BioTherapeutics, Inc. PLX | 10 percent owner | 857,506 1.9156% | $2.25 | $1.93M | -48.2% | |
| 2021-06-02 | Sale | Protalix BioTherapeutics, Inc. PLX | 10 percent owner | 61,211 0.1389% | $2.56 | $156,553 | -53.63% |